Chronic myelopathy associated with human T-lymphotropic virus type I (HTLV-I)
A Gessain, O Gout - Annals of Internal Medicine, 1992 - acpjournals.org
▪ Purpose: To review the clinical, epidemiologic, immunologic, and virologic aspects of the
chronic myelopathy associated with human T-cell leukemia/lymphoma virus type I (HTLV-I) …
chronic myelopathy associated with human T-cell leukemia/lymphoma virus type I (HTLV-I) …
MRI features of demyelinating disease associated with anti-MOG antibodies in adults
M Deneve, D Biotti, S Patsoura, M Ferrier… - Journal of …, 2019 - Elsevier
Abstract The spectrum of Myelin Oligodendrocytes Glycoprotein (MOG) antibody disease
constitutes a recently described challenging entity, referring to a relatively new spectrum of …
constitutes a recently described challenging entity, referring to a relatively new spectrum of …
Biofilm-like extracellular viral assemblies mediate HTLV-1 cell-to-cell transmission at virological synapses
AM Pais-Correia, M Sachse, S Guadagnini… - Nature medicine, 2010 - nature.com
The virus HTLV-1 is thought to pass between cells through synapses formed when infected
lymphocytes make contact with other T cells. Isabelle Thoulouze and her colleagues …
lymphocytes make contact with other T cells. Isabelle Thoulouze and her colleagues …
MD1003 (high-dose biotin) for the treatment of progressive multiple sclerosis: a randomised, double-blind, placebo-controlled study
A Tourbah, C Lebrun-Frenay, G Edan… - Multiple Sclerosis …, 2016 - journals.sagepub.com
Background: Treatment with MD1003 (high-dose biotin) showed promising results in
progressive multiple sclerosis (MS) in a pilot open-label study. Objective: To confirm the …
progressive multiple sclerosis (MS) in a pilot open-label study. Objective: To confirm the …
Neuromyelitis optica in France: a multicenter study of 125 patients
N Collongues, R Marignier, H Zephir, C Papeix… - Neurology, 2010 - AAN Enterprises
Background: There have been few epidemiologic studies on neuromyelitis optica (NMO)
and none used the recent 2006 diagnostic criteria. Here we describe the clinical, laboratory …
and none used the recent 2006 diagnostic criteria. Here we describe the clinical, laboratory …
[HTML][HTML] High doses of biotin in chronic progressive multiple sclerosis: a pilot study
F Sedel, C Papeix, A Bellanger, V Touitou… - Multiple sclerosis and …, 2015 - Elsevier
Background No drug has been found to have any impact on progressive multiple sclerosis
(MS). Biotin is a vitamin acting as a coenzyme for carboxylases involved in key steps of …
(MS). Biotin is a vitamin acting as a coenzyme for carboxylases involved in key steps of …
Rapid development of myelopathy after HTLV-I infection acquired by transfusion during cardiac transplantation
O Gout, M Baulac, A Gessain, F Semah… - … England Journal of …, 1990 - Mass Medical Soc
HUMAN T-cell lymphotropic virus Type I (HTLV-I), considered to be the causative agent of
adult T-cell lymphoma/leukemia, 1, 2 is also associated with a chronic myelopathy (tropical …
adult T-cell lymphoma/leukemia, 1, 2 is also associated with a chronic myelopathy (tropical …
Safety and efficacy of opicinumab in patients with relapsing multiple sclerosis (SYNERGY): a randomised, placebo-controlled, phase 2 trial
D Cadavid, M Mellion, R Hupperts… - The Lancet …, 2019 - thelancet.com
Background Opicinumab is a human monoclonal antibody against LINGO-1, an inhibitor of
oligodendrocyte differentiation and axonal regeneration. Previous findings suggested that …
oligodendrocyte differentiation and axonal regeneration. Previous findings suggested that …
Acute fulminant demyelinating disease: a descriptive study of 60 patients
J de Seze, M Debouverie, H Zephir… - Archives of …, 2007 - jamanetwork.com
Background Acute demyelinating encephalomyelitis (ADEM) is characterized by a severe
inflammatory attack, frequently secondary to infectious events or vaccinations. To date, no …
inflammatory attack, frequently secondary to infectious events or vaccinations. To date, no …
Interferon-β treatment in patients with childhood-onset multiple sclerosis
Y Mikaeloff, T Moreau, M Debouverie, J Pelletier… - The Journal of …, 2001 - Elsevier
Interferon-β treatment in patients with childhood-onset multiple sclerosis - ScienceDirect Skip to
main contentSkip to article Elsevier logo Journals & Books Search RegisterSign in View PDF …
main contentSkip to article Elsevier logo Journals & Books Search RegisterSign in View PDF …